Affiliation:
1. HOD of Community Health Department, Joitiba College of Nursing, Bhandu, Dist.- Mehsana.
2. 2nd Year M.sc Nursing Student, Joitiba College of Nursing, Bhandu, Dist.- Mehsana.
Abstract
Introduction: Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available HPV vaccine protect against either two, four, or nine types of HPV. All HPV vaccines protect against at least HPV types 16and18, which cause the greatest risk of cervical cancer. It is estimated that HPV vaccine may prevent 70% of cervical cancer. Cervical cancer is persistent infection with high-risk types of human papillomavirus an extremely common family of viruses that are transmitted through sexual contact.1 Design: A quantitative approach using pre experimental one group pre-test post-test design. Participants: 100 women were selected using non probability convenience sampling technique in selected rural area of mehsana district. Intervention: planned health teaching programme was given to the women. Tool: self-structured questionnaire was used to assess the level of knowledge of women regarding HPV vaccine for cervical cancer. Results: in this study overall the highest percentage in the demographic data including Age group 40% (19-21year), religion 76% (Hindu), Marital status 83% (unmarried), Education 43% (higher Secondary), Occupation 40% (Home maker), and family income 35% (below poverty), Previous knowledge 65% (Yes), The post- test Knowledge mean score (14.1±3.26) higher than the mean pre-test knowledge score (8.25±3.10). The calculated “t’’ value (13.29) was greater than the table value (1.98) at 0.05 level of significance. The planned health teaching programme was effective in increasing the knowledge of women regarding HPV vaccine for cervical cancer. Conclusion: The findings of the study revealed that planned teaching programme helps in improving knowledge regarding HPV vaccine for cervical cancer among the women.
Reference10 articles.
1. Human papillomavirus vaccines: WHO position paper, May 2017". Relevé Épidémiologique Hebdomadaire. 92 (19): 241–268. May 2017.
2. Noman campaign, Website-https://www.nomancampaign.org/post/the-history-of-the-hpv-vaccine
3. Tino F, Schwarz. Recent Advance in cervical cancer prevention. Expert review of vaccines. 2008;7(10):1465-73.
4. Human papillomavirus HPV vaccines. QandA National Cancer Institute (internet)2008July7[citedon2010Oct16] Available from: Website https://www.cancer.gov/cancertopics/factsheet/risk/hpvvaccine
5. The association of women’s health. obstetric and neonatal nurses(internet).2009, available from: Website -https://onlinelibrary.wiley.com